Bull Horn Holdings Corp.

Bull Horn Holdings Corp.

BHSEU
Bull Horn Holdings Corp.US flagNASDAQ Capital Market
12.96
USD
+3.36
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
Robert Striar
Sector
Financial Services
Industry
Shell Companies
Address
801 South Pointe Drive Miami Beach FL United States of America 33139
IPO Date
Oct 30, 2020
Business
Bull Horn Holdings Corp. (NASDAQ: BHSEU) operates as a blank check company, or special purpose acquisition company (SPAC), focused on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses primarily in the sports, entertainment, and brand sectors; it offers no significant products or services beyond its SPAC structure, which facilitates public listings for target companies through reverse mergers. Incorporated in 2018 and headquartered in Miami Beach, Florida, at 801 South Pointe Drive, the company maintains its operational base in the United States with a strategy targeting high-growth opportunities in media, technology, and related industries. In a major development, Bull Horn Holdings completed a reverse merger with Coeptis Therapeutics, Inc. on October 28, 2022, resulting in the combined entity renaming to Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), which shifted focus to biopharmaceutical cell therapy platforms for cancer treatment while former Bull Horn units continued trading under BHSEU. This transaction marked the primary strategic execution for Bull Horn, with Coeptis stockholders owning approximately 88% of the post-merger company and Nasdaq uplisting enhancing liquidity; no further acquisitions, partnerships, funding rounds, or operational expansions have been reported for Bull Horn Holdings independently since the merger. The company's website at www.bullhornse.com provides SEC filings and compliance details, underscoring its sports and entertainment SPAC mandate amid ongoing unit trading activity.

Company News

APIChat
  • Bull Horn (OTCMKTS:BHSEU) Stock Price Up 35% – Still a Buy?

  • Bull Horn (OTCMKTS:BHSEU) Stock Price Up 35% – What’s Next?

  • Bull Horn Holdings Corp. Announces Separate Trading of its Ordinary Shares and Warrants, Commencing December 17, 2020